This bill provides for Medicare coverage of multimarker tests related to ovarian cancer (i.e., tests that evaluate more than one tumor marker with respect to ovarian cancer).
Actions
Oct 3, 2022
Referred to the Subcommittee on Health.
Sep 30, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.